Sponsored by the Miller School and presented by the Department of Neurological Surgery, the 4th Annual “Therapeutic Hypothermia and Temperature Management: Current and Future” symposium will be held March 6-7 from 7 a.m. to 5 p.m. at the Marriott Biscayne Bay, 1633 North Bayshore Drive, Miami.
News : 2013
When Danielle Press went boating off Key Biscayne the afternoon of September 14, she didn’t realize she would be severely injured in a boating accident and make medical history. One month after being rushed to Ryder Trauma Center, surgeons from the Miller School of Medicine/Jackson Memorial Hospital performed the world’s first nerve graft using a combination of Press’ own nerve and Schwann cells.
Mary Bartlett Bunge, Ph.D., professor of cell biology, neurological surgery and neurology at the Univerisity of Miami Miller School of Medicine’s Miami Project to Cure Paralysis, has been elected to the National Academy of Sciences Institute of Medicine, an extraordinary honor that reflects the height of professional achievement and commitment to service in health and medicine.
Ralph L. Sacco, M.D., M.S., professor and Chair of Neurology and the Olemberg Family Chair in Neurological Disorders, has been appointed to the NIH’s National Advisory Neurological Disorders and Stroke Council, the principal advisory body to the National Institute of Neurological Disorders and Stroke (NINDS).
A revolutionary brain cancer vaccine clinical trial once limited to patients with newly diagnosed glioblastoma multiforme is now offered to UHealth patients with a recurrent brain tumor. As in the original study, the patient’s own tumor cells are used to develop the vaccine that is designed to target the immune system, offering hope to those with the most common and aggressive form of brain tumor.
Borrowing a treatment strategy proven to work for Parkinson’s disease, a multidisciplinary team of researchers led by Ian D. Hentall, Ph.D., research associate professor of neurological surgery, and Jonathan Jagid, M.D., associate professor of neurological surgery, expect to begin a clinical trial soon to determine if electrically stimulating the brain of spinal cord-injuried patients can reduce pain and other symptoms. .
Enrique Ginzburg, M.D., professor of surgery, has been appointed by Governor Rick Scott to serve as a member of the Florida Board of Medicine. Joining another UM faculty member on the board, he will serve a three-year term on the quasi-judicial panel responsible for disciplining physicians. A veteran trauma surgeon, Ginzburg also serves as Chief of Surgery at University of Miami Hospital.
A consortium of discovery science researchers within The Miami Project to Cure Paralysis has received a $2.5 million, 18-month grant from the U.S. Army Medical Research and Materiel Command. Titled “U.S. Army Battlefield Exercise & Combat Related SCI,” the award will enable the investigation of new treatments for spinal cord injury.
When Thomas Jambeck was diagnosed with brain tumors caused by metastatic melanoma in 2011, the 64-year-old West Palm Beach resident underwent radiation and two surgeries. One tumor responded, but the second doubled in size. That’s when his physicians sent him to the Miller School for what would be a life-changing procedure.
Another record crowd came out for this year’s Brain Fair at the Miami Science Museum, organized by University of Miami scientists and colleagues from several other institutions. The free science event drew more than 3,000 children of all ages who learned how the brain works through an array of hands-on activities.
Researchers at The Miami Project to Cure Paralysis have published six-year findings in the journal Spinal Cord, the official journal of the International Spinal Cord Society, that provide additional evidence that the use of mild hypothermia is a safe and effective strategy for treating acute spinal cord injuries.
To cheers, honking horns and loud applause, Roy Roden and his wife Lynn pedaled their bikes to the Schoninger Research Quadrangle on the Miller School campus Friday, completing a 4,500-mile ride that started in Seattle last November to raise awareness and research funds for Parkinson’s disease.
The first two stroke patients have been enrolled in a phase 2 clinical trial of a revolutionary new treatment for ischemic stroke being conducted at the University of Miami/Jackson Memorial Hospital. The trial, using a patient’s own bone marrow stem cells, is the first intra-arterial stroke stem cell trial in the U.S., and the two UM/Jackson patients are the first in Florida to participate.